Shows / Decera Clinical Education Oncology Podcast
Decera Clinical Education Oncology Podcast
Updates on new data and best practices in the care of patients with cancer across a wide variety of solid tumors and hematologic malignancies from Decera Clinical Education. Gain practical clinical insights and strategies and earn CME/CE credit for selected episodes.
Episodes
Decera Clinical Education Oncology PodcastTROP2-Directed ADCs in NSCLC: Current Evidence, Emerging Therapies, and Future Treatment Strategies
In this podcast episode, Christine M. Bestvina, MD, and Joshua E. Reuss, MD, discuss the current and emerging role of TROP2-directed ADCs in NSCLC, including…
Decera Clinical Education Oncology PodcastExperts Discuss Key Topics in Treatment for Newly Diagnosed Multiple Myeloma
In this podcast episode, Jesus G. Berdeja, MD, and Ajai Chari, MD, discuss evolving therapy in newly diagnosed multiple myeloma, including: Selecting…
Decera Clinical Education Oncology PodcastPARP Inhibitors in Metastatic Prostate Cancer: Biomarker Testing, Treatment Strategies, and Toxicity Management
In this podcast episode, Neeraj Agarwal, MD, FASCO, and Emmanuel S. Antonarakis, MD, discuss the evolving role of PARP inhibitors in metastatic prostate…
Decera Clinical Education Oncology PodcastExperts Discuss Sequencing of Therapies for Relapsed/Refractory Multiple Myeloma
Listen to Jesus G. Berdeja, MD, and Ajai Chari, MD, as they discuss sequencing of antibody–drug conjugates (ADCs), bispecific antibodies, CAR T-cell therapy…
Decera Clinical Education Oncology PodcastASCO 2026 Updates in Metastatic Breast Cancer
In this podcast episode, Hope S. Rugo, MD, FASCO, and Nerea Lopetegui-Lia, MD, discuss practice-informing data presented at ASCO 2026 for patients with…
Decera Clinical Education Oncology PodcastEvolving Role of B7-H3–Directed ADCs in the Extensive-Stage Small-Cell Lung Cancer Treatment Landscape
In this podcast episode, Charles Rudin, MD, PhD, and Mark A. Socinski, MD, discuss current gaps and clinical needs for patients with relapsed ES-SCLC, and the…
Decera Clinical Education Oncology PodcastTargeting CDH6 in Platinum-Resistant Ovarian Cancer: Emerging ADCs, Biomarkers, and Sequencing
In this podcast episode, BJ Rimel, MD, and Elizabeth Lee, MD, discuss the scientific rationale for targeting CDH6 in ovarian cancer and the emerging role of…
Decera Clinical Education Oncology PodcastASCO 2026 Updates in Early Hormone Receptor–Positive Breast Cancer
In this podcast episode, Hope S. Rugo, MD, FASCO, and Nerea Lopetegui-Lia, MD, discuss practice-informing data presented at ASCO 2026 for patients with…
Decera Clinical Education Oncology PodcastCELMoDs on the Horizon: A New Chapter in Lymphoma Care
Treatment options for patients with lymphoma are rapidly evolving. In this podcast episode, Alex F. Herrera, MD, and Marc Hoffmann, MD, discuss cereblon E3…
Decera Clinical Education Oncology PodcastExperts Discuss Health Disparities and Equitable Care Strategies in Multiple Myeloma
In this podcast episode, Jesus G. Berdeja, MD, and Ajai Chari, MD, discuss health disparities and equitable care strategies in multiple myeloma, including…
Decera Clinical Education Oncology PodcastExperts Discuss CELMoD Agents for Multiple Myeloma
In this podcast episode, Meletios-Athanasios (Thanos) C. Dimopoulos, MD, and María-Victoria Mateos, MD, PhD, as they discuss the use of CELMoD agents to manage…
Decera Clinical Education Oncology PodcastOptimizing Oral Targeted Therapies for HR+/HER2- Breast Cancer
In this episode, Danielle Roman, PharmD, BCOP, and Jordan Hill, PharmD, BCOP, discuss optimal care for patients with HR-positive/HER2-negative breast cancer…
Decera Clinical Education Oncology PodcastTGCT Today: Understanding Diagnosis, Treatment, and Long-term Care
Tenosynovial giant cell tumor (TGCT) is a rare, locally aggressive disease that can cause chronic pain, joint dysfunction, reduced mobility, and significant…
Decera Clinical Education Oncology PodcastOptimizing Anti-CD38–Based Treatment for Smoldering and Newly Diagnosed Multiple Myeloma: Pharmacist Perspectives
In this podcast episode, James A. Davis, PharmD, BCOP, and Kelley L. Julian, PharmD, BCOP, discuss evidence-based strategies for managing smoldering and newly…
Decera Clinical Education Oncology PodcastNew and Emerging Targeted Therapies for Patients With DLBCL
In this podcast episode, Gilles Salles, MD, PhD, and Pier Luigi Zinzani, MD, PhD, discuss the role of new and emerging targeted therapies in the management of…
Decera Clinical Education Oncology PodcastChanging the Paradigm in HER2-Positive Early Breast Cancer
New data and broad indications for trastuzumab deruxtecan are changing the paradigm for HER2-positive early breast cancer. Listen to Shanu Modi, MD, and Sara…
Decera Clinical Education Oncology PodcastRecent Advances, Future Directions, and Ideas on Integrating CELMoDs Into The Care Of Patients With Myeloma
Listen in to learn from Sagar Lonial, MD, and Mohamad Mohty MD, PhD, about the advantages and future implications of the next-generation protein degradation…
Decera Clinical Education Oncology PodcastTo Treat or Not to Treat: Assessing Risk and Treatment Options in High-Risk SMM
In this podcast episode, Natalie S. Callander, MD, and Tom Martin, MD, discuss the optimal approaches for the determination of whether a patient with high-risk…
Decera Clinical Education Oncology PodcastUnmet Needs, Recent Advances, and Expert Insights on Integrating TROP-2 ADCs Into the Care of Patients With TNBC
Listen in to learn from Thomas Bachelot, MD, PhD, and Mafalda Oliveira, MD, PhD, about recent advances and the integration of anti-TROP2 antibody-drug…
Decera Clinical Education Oncology PodcastOptimizing Bispecific Antibody Safety and Care Coordination From the Pharmacy in RRMM
In this episode, Dr Sara Ann Scott and Dr Syeda Saba Kareem discuss toxicities and the safe management of bispecific antibodies used in the treatment of RRMM…
Decera Clinical Education Oncology PodcastTargeting the Future of Pancreatic Cancer Care: RAS, Biomarkers, and Emerging Therapies
In this episode, Dr Paul E. Oberstein, Dr Andrew H. Ko, and Dr Efrat Dotan discuss recent advances in pancreatic cancer, including: The evolving role of…
Decera Clinical Education Oncology PodcastBeyond BCMA: How GPRC5D-Targeted Therapy Fits into Multiple Myeloma Care Today
Treatment options for patients with multiple myeloma are rapidly evolving. In this podcast episode, Jesus Berdeja, MD, and Amrita Krishnan, MD, FCAP, discuss…
Decera Clinical Education Oncology PodcastWhat Oncology Pharmacists Need to Know About Targeting BCMA in Early Relapsed/Refractory Myeloma
In this podcast episode, Donald Moore, PharmD, BCPS, BCOP, DPLA, FCCP, FASHP, and Anthony Perissinotti, PharmD, BCOP, discuss the role, efficacy, and safety of…
Decera Clinical Education Oncology PodcastIncorporating AKT1 and PIK3CA Pathway Testing and Targeted Therapies in the Management of Advanced Endocrine-Resistant Breast Cancer
Listen in to learn from Cristina Saura Manich, MD, PhD and Giampaolo Bianchini, MD about practical approaches to PI3K pathway testing, PI3K/AKT-targeted…
Decera Clinical Education Oncology PodcastPersonalizing EGFR Mutation–Positive NSCLC Care: Strategies for the Advanced Practice Provider
Link to claim CME credit: https://bit.ly/4uRr3ir In this episode, Elizabeth Krueger, NP, and Sam Vafadar, DHSc, PA-C, discuss how they optimize first-line…
Decera Clinical Education Oncology PodcastAdvancing the Early Detection of Lung Cancer: Expanding Screening Access, Eligibility, and Awareness
In this episode, Dr Abbie Begnaud discusses the importance of lung cancer screening and evolving strategies to improve early detection among high-risk…
Decera Clinical Education Oncology PodcastHNSCC: Current and Emerging Therapeutic Strategies
In this episode, Aarti Bhatia, MD, MPH, and Deborah J. Wong, MD, PhD, discuss the rapidly evolving treatment landscape for recurrent, metastatic, and locally…
Decera Clinical Education Oncology PodcastNavigating Relapsed/Refractory Multiple Myeloma: Real-world Use of Bispecific Antibodies
In this episode, hear Doris K. Hansen, MD, discuss the management of relapsed/refractory multiple myeloma with bispecific antibodies including: Practical…
Decera Clinical Education Oncology PodcastOncologists “On Call”: Our Practical Experiences to Optimizing Bispecific Antibody Therapy in Relapsed/Refractory Multiple Myeloma
In this episode, Muhamed Baljevic, MD, FACP, and Johnathan Ticku, MD, discuss various strategies to optimize the use of bispecific antibodies in their…
Decera Clinical Education Oncology PodcastThrombotic Events and ET/PV: What You Should Know
In this episode, hear Anthony Hunter, MD and Douglas Tremblay, MD discuss the various presentations of thrombotic events in patients with PV or ET including…
Decera Clinical Education Oncology PodcastGlobal Experts Discuss Current and Emerging Treatments for ET and PV
In this podcast episode, Ciro Rinaldi MD, PhD, and Alessandro M. Vannucchi, MD, discuss contemporary management of essential thrombocythemia (ET) and…
Decera Clinical Education Oncology PodcastGlobal Experts Discuss Diagnostic Considerations in ET and PV
In this podcast episode, Ciro Rinaldi, MD, PhD, and Alessandro M. Vannucchi, MD, as they discuss contemporary topics in diagnosing essential thrombocythemia…
Decera Clinical Education Oncology PodcastExperts Discuss Novel Approaches to First-line Therapy for HER2-Positive Metastatic Breast Cancer
In this podcast episode, Erika Hamilton, MD, FASCO, and Ian Krop, MD, PhD, discuss recent developments in the field of first-line therapy and maintenance…
Decera Clinical Education Oncology PodcastPatient Voices: Caring for the Whole Patient and Personalizing Treatment of Early Breast Cancer to Achieve Equitable Outcomes
A patient advocate/cancer survivor and a healthcare professional discuss key topics including early breast cancer diagnosis, role of self-agency in pursuing…
Decera Clinical Education Oncology PodcastRole of AKT and PI3K Inhibitors in Patients With HR-Positive Breast Cancers: Experts Share Their Thoughts on Current Practice and Future Opportunities
Podcast with global experts discussing the role of AKT and PI3K inhibitors in patients with resistance to endocrine therapy in the adjuvant or metastatic…
Decera Clinical Education Oncology PodcastPatient-Centered Management of CDK4/6 Inhibitor Therapy: Adverse Event Mitigation, Adherence, and Persistence in HR+/HER2- Breast Cancer
In this episode, Danielle Roman, PharmD, BCOP, and Jordan Hill, PharmD, BCOP, discuss patient-centered management of CDK4/6 inhibitor therapy in…
Decera Clinical Education Oncology PodcastTROP2-Directed Antibody–Drug Conjugates in Non-Small-Cell Lung Cancer: Current Use in Clinical Practice and Future Directions
In this episode, Dr Matthew Gubens and Dr Helena Yu discuss the evolving role of TROP2-directed therapies in non-small-cell lung cancer, with a focus on how…
Decera Clinical Education Oncology PodcastEmerging Therapies for Patients With HER2+ Gastroesophageal Adenocarcinoma and Biliary Tract Cancer
In this podcast episode, Amit Mahipal, MD, MPH, and Shubham Pant, MD, discuss new and emerging therapies for the individualized care of patients with…
Decera Clinical Education Oncology PodcastExperts Discuss ADCs for HER2-Negative/Ultralow/Low MBC
In this podcast episode, Aditya Bardia, MD, MPH, FASCO, and Ruta Rao, MD, discuss ADCs for HER2-negative/ultralow/low metastatic breast cancer, including…
Decera Clinical Education Oncology PodcastAdvanced Practice Professionals on Biomarker Testing in Patients With Solid Tumors: Colorectal Cancer
Advanced practice providers discuss biomarker testing in patients with colorectal cancer. Listen in to learn from Ann Marie Siney, RN, MSN, ANP-BC, and…
Decera Clinical Education Oncology PodcastAdvanced Practice Professionals on Biomarker Testing in Patients With Solid Tumors: Prostate Cancer
Listen to this audio podcast covering biomarker testing in patients with prostate cancer. Learn from Sara Traverso, MMS, PA-C, and Brenda Martone, MSN, ANP-BC…
Decera Clinical Education Oncology PodcastBladder Cancer Breakthroughs: New NMIBC Therapies and EV + Pembrolizumab Updates From ASCO GU 2026
In this episode, Sam S. Chang, MD, MBA, and Matthew D. Galsky, MD, discuss the rapidly evolving treatment landscape in bladder cancer, highlighting new…
Decera Clinical Education Oncology PodcastMyth vs Medicine: Pharmacist’s Perspective on Adjuvant CDK4/6 Inhibitor Optimization
In this episode, oncology pharmacists Julia L. Ziegengeist, PharmD, BCOP, and Rodney Hunter, PharmD, BCOP, explore and challenge common assumptions about…
Decera Clinical Education Oncology PodcastFrom ASH 2025 to the Clinic: Global Perspectives on Evolving BTK Therapies in Relapsed/Refractory CLL
In this episode, Matthew S. Davids, MD, MMSc; Nelson Hamerschlak, MD, PhD; and Stephen Stilgenbauer, MD, discuss how recently presented data from ASH 2025 are…
Decera Clinical Education Oncology Podcast2025 San Antonio Breast Cancer Symposium Conference Coverage: Highlights Podcast
Listen to learn from Sara M. Tolaney, MD, MPH, and Virginia Kaklamani, MD, DSc, about new clinical trial data and updates informing the care of patients with…
Decera Clinical Education Oncology PodcastAdvancing KRAS G12C-Targeted Therapies in NSCLC: Current Evidence and Future Directions
In this episode, Dr Paz-Ares and Dr Christine Bestvina discuss the evolving role of KRAS G12C inhibitors in non-small-cell lung cancer (NSCLC), including…
Decera Clinical Education Oncology PodcastBeyond Chemotherapy in ALL: Emerging Bispecific Antibodies, CAR T-cell Therapies, and Evolving Treatment Strategies
In this episode, Dr Ibrahim Aldoss and Dr Bijal Shah discuss how immunotherapy has transformed the treatment landscape of acute lymphoblastic leukemia (ALL)…
Decera Clinical Education Oncology PodcastExperts Discuss Novel RAS-Targeted Therapy for Pancreatic Cancer
In this podcast episode, Nilofer Azad, MD, FASCO, and Zev A. Wainberg, MD, discuss novel RAS-targeted therapies for pancreatic cancer, including the following…
Decera Clinical Education Oncology PodcastAdvanced Practice Professionals Discuss Biomarker Testing in Patients With Solid Tumors: Lung Cancer
Advanced practice providers discuss biomarker testing in patients with lung cancer. Listen in to learn from Beth Sandy, MSN, CRNP,FAPO, and Denise Rouse, MS…
- Decera Clinical Education Oncology Podcast
Individualized Hemophilia Care With Hemostatic Rebalancing Therapies
In this podcast episode, experts Angela Weyand and Guy Young discuss their experience using hemostatic rebalancing agents for prophylaxis in patients diagnosed…
Decera Clinical Education Oncology PodcastExperts Offer Guidance on Shared Decision-making in the Management of Patients With PV/ET
In this episode, hear Joan How, MD and Pankit Vachhani, MD share their insights on the importance of shared decision-making (SDM) for patients with…
Decera Clinical Education Oncology PodcastExperts Discuss CELMoD Agents for Treating Multiple Myeloma
In this podcast episode, Jesus Berdeja, MD; Amrita Krishnan, MD, FACP; and Niels van de Donk, MD, PhD, address key questions on CELMoD agent therapy for…
Decera Clinical Education Oncology PodcastPulseCast: Highlights in MDS/MPNs From the 2025 ASH Annual Meeting
In this podcast episode, Rami Komrokji, MD, reviews data from select presentations in myelodysplastic syndromes (MDS) and myeloproliferative neoplasms (MPNs)…
Decera Clinical Education Oncology PodcastExpert Highlights From the 2025 World Conference on Lung Cancer
In this episode, Dr John Heymach and Dr Solange Peters discuss key data presented at the IASLC World Conference on Lung Cancer including first-line maintenance…
Decera Clinical Education Oncology PodcastPulseCast: Highlights in Multiple Myeloma From the 2025 ASH Annual Meeting
In this episode, Shaji K. Kumar, MD, reviews key highlights from ASH 2025 in multiple myeloma (MM), focusing on emerging data for bispecific antibodies and CAR…
Decera Clinical Education Oncology PodcastPulseCast: Highlights in Lymphomas From the 2025 ASH Annual Meeting
In this podcast episode, Jeremy S. Abramson, MD, MMSc, reviews data from select presentations in lymphomas at the ASH 2025 Annual Meeting and provides…
Decera Clinical Education Oncology PodcastPulseCast: Highlights in Nonmalignant Blood Disorders From the 2025 ASH Annual Meeting
In this episode, Hanny Al-Samkari, MD, gives his thoughts on 5 key presentations from ASH 2025, and provides perspectives on the clinical implications of these…
Decera Clinical Education Oncology PodcastPulseCast: Highlights in Leukemias From the 2025 ASH Annual Meeting
In this podcast episode, Amir T. Fathi, MD, reviews data from select presentations in leukemias at the ASH 2025 Annual Meeting, and provides perspectives on…
Decera Clinical Education Oncology PodcastTROP2 and TIGIT Therapies for Advanced NSCLC: Where Are We Today?
In this episode, Benjamin Levy, MD, FASCO, and Alex Spira, MD, PhD, FASCO, discuss the latest developments in targeting TROP2 and TIGIT for the treatment of…
Decera Clinical Education Oncology PodcastA Newly Approved Targeted Combination Therapy for KRAS-Mutant Low-Grade Serous Ovarian Cancer
In this episode, Dr Rachel Grisham and Dr Kathleen Moore discuss newly approved treatments for low-grade serous ovarian cancer (LGSOC) and how recent research…